The Criticality of Good Regulatory Strategy in Path to Market Planning – A Small Company, Rare Renal Disease Perspective
Time: 4:30 pm
day: Conference Day Two
Details:
- Maximising chances of success by correctly sequencing regulatory activities with the Division review team and OOPD
- Taking the time to find alignment and involve independent experts in every stage of the regulatory pathway – genuine, authentically independent experts can be very influential
- Making it paramount to establish a collaborative relationship because everyone has the same goal: to bring improved treatment options to patients
